WDC
37
-3
JBHT
56
-3
HUM
41
-4
DG
8
-2
DTE
43
5
ZBH
65
3
TGNA
50
-6
MAS
52
-4
AIV
64
4
COST
57
-6
HBI
58
3
AIZ
82
2
FMC
23
-3
PLD
45
-5
CAT
59
-2
SNA
70
-5
RL
69
-4
KIM
72
2
DFS
64
2
PAYX
48
-6
WDC
37
-3
JBHT
56
-3
HUM
41
-4
DG
8
-2
DTE
43
5
ZBH
65
3
TGNA
50
-6
MAS
52
-4
AIV
64
4
COST
57
-6
HBI
58
3
AIZ
82
2
FMC
23
-3
PLD
45
-5
CAT
59
-2
SNA
70
-5
RL
69
-4
KIM
72
2
DFS
64
2
PAYX
48
-6
Financhill
Back

Invesco FTSE RAFI Dev Mkts ex-US S/M ETF Vs. Avidity Biosciences Industry Stock Comparison

Sell
50

PDN
Invesco FTSE RAFI Dev Mkts ex-US S/M ETF

Last Price:
32.10
Seasonality Move:
0.9%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
50
Invesco FTSE RAFI Dev Mkts ex-US S/M ETF (PDN) is a Sell

Is Invesco FTSE RAFI Dev Mkts ex-US S/M ETF a Buy, Sell or Hold?

  • The current Invesco FTSE RAFI Dev Mkts ex-US S/M ETF [PDN] share price is $32.09. The Score for PDN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • PDN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PDN Stock Price Chart

What is Invesco FTSE RAFI Dev Mkts ex-US S/M ETF's stock price today?

  • The Invesco FTSE RAFI Dev Mkts ex-US S/M ETF share price today is $32.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDN is experiencing slight selling pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

PDN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.11 Sell
Chaikin Money Flow: -759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.54 - 33.76) Sell
Bollinger Bands (100): (32.71 - 34.47) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

PDN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.58 Sell
20-day SMA: 32.92 Sell
50-day SMA: 33.87 Sell
200-day SMA: 33.06 Sell
8-day EMA: 32.46 Sell
20-day EMA: 32.93 Sell
50-day EMA: 33.43 Sell
200-day EMA: 33.01 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Invesco FTSE RAFI Dev Mkts ex-US S/M ETF Earnings Growth & PDN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

Invesco FTSE RAFI Dev Mkts ex-US S/M ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):